Company Filing History:
Years Active: 2010-2024
Title: Gerhard Randers-Pehrson: Innovator in Viral and Bacterial Research
Introduction
Gerhard Randers-Pehrson is an accomplished inventor based in Ossining, NY. With an impressive portfolio of 23 patents, his work primarily focuses on developing innovative solutions to combat viral and bacterial infections. His latest inventions leverage advanced radiation technologies to selectively target and eliminate pathogens, showcasing his commitment to improving public health.
Latest Patents
Randers-Pehrson's recent patents include a groundbreaking "Apparatus, method and system for selectively affecting and/or killing a virus." This invention describes an apparatus capable of generating radiation specifically designed to affect viruses by emitting wavelengths between 200 nm and 230 nm while also ensuring that harmful radiation is filtered out, protecting healthy cells.
Another notable patent is the "Apparatus, method, and system for selectively affecting and/or killing bacteria." Similar to his viral research, this patent details a method for producing radiation that can target bacteria effectively, using wavelengths from 190 nm to 230 nm. Both inventions are significant contributions to the field, potentially aiding in the development of more effective treatments against infectious diseases.
Career Highlights
Randers-Pehrson is currently affiliated with Columbia University in the City of New York, where his research continues to push the boundaries of medical technology. His work not only contributes to academic knowledge but also has practical applications in healthcare and disease prevention.
Collaborations
Throughout his career, Randers-Pehrson has collaborated with esteemed colleagues, including David Jonathan Brenner and Alan Bigelow. These partnerships emphasize the importance of teamwork in scientific research, combining diverse expertise to achieve innovative breakthroughs.
Conclusion
Gerhard Randers-Pehrson stands out as a leading inventor committed to address pressing health challenges through innovative technologies. His contributions to viral and bacterial research not only illustrate his ingenuity but also his dedication to enhancing public health through pioneering inventions. As he continues his work at Columbia University, the impact of his patents will likely resonate in both the scientific community and society at large.